Winfield Associates’s Patterson-UTI PTEN Stock Holding History
Bought
Maintained
Sold
Other funds holding PTEN
PP
Winfield Associates's PTEN Position: Q1 2018 in Review
Winfield Associates sold out of Patterson-UTI (PTEN) in Q1 2018, closing a stake of 165 shares — an estimated $4K sold.
Winfield Associates first reported a position in PTEN in Q2 2016 and held it in 6 quarters. The position peaked at $4K in Q4 2017. 327 funds tracked by Wall St. Rank hold PTEN as of Q1 2018.
- Winfield Associates reported no remaining Patterson-UTI position as of Q1 2018 after selling out during the quarter.
- Winfield Associates sold 165 Patterson-UTI shares in Q1 2018, an estimated $4K.
- Winfield Associates first reported a position in Patterson-UTI in Q2 2016 and held it in 6 quarters.
- Winfield Associates's Patterson-UTI position peaked at $4K in Q4 2017.
- 327 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2018.
Based on Winfield Associates's 13F filing for Q1 2018, filed 10 May 2018.